Efflux pumps in multidrug-resistant Acinetobacter baumannii: Current status and challenges in the discovery of efflux pumps inhibitors

P Verma, M Tiwari, V Tiwari - Microbial pathogenesis, 2021 - Elsevier
Acinetobacter baumannii is an ESKAPE pathogen known to cause fatal nosocomial
infections. With the surge of multidrug resistance (MDR) in the bacterial system, effective …

Expression of RND efflux pumps mediated antibiotic resistance in Pseudomonas aeruginosa clinical strains

M Rahbar, R Hamidi-Farahani, A Asgari… - Microbial …, 2021 - Elsevier
Abstract Resistance-Nodulation-Division (RND) efflux pumps are responsible for multidrug
resistance in Pseudomonas aeruginosa. The present study aimed to evaluate the …

Synthesis, structural, characterization, antibacterial and antibiotic modifying activity, ADMET study, molecular docking and dynamics of chalcone (E)-1-(4-aminophenyl)-3-(4 …

MA Souza, LG Rodrigues, JE Rocha… - Journal of …, 2024 - Taylor & Francis
Chalcones have an open chain flavonoid structure that can be obtained from natural
sources or by synthesis and are widely distributed in fruits, vegetables, and tea. They have a …

Evaluation of phyto-gallic acid as a potential inhibitor of Staphylococcus aureus efflux pump mediated tetracycline resistance: an in-vitro and in-silico study

NMS Moubayed, R Alsabbagh… - Natural Product …, 2024 - Taylor & Francis
Plants contain many bioactive compounds with potent antibacterial and efflux pump
inhibitory activity (EPI). In this study, gallic acid extracted from pomegranate molasses by …

Microbial efflux pump inhibitors: A journey around quinoline and indole derivatives

G Cernicchi, T Felicetti, S Sabatini - Molecules, 2021 - mdpi.com
Antimicrobial resistance (AMR) is a complex threat to human health and, to date, it
represents a hot topic in drug discovery. The use of non-antibiotic molecules to block …

Quantum-chemical calculation, antibiotic potentiating activity, evaluation of efflux pump inhibition against S. aureus multi-resistant strains and molecular docking of the …

AJDM Bento, FW de Queiroz Almeida-Neto… - Journal of Molecular …, 2024 - Elsevier
In recent years, due to the uncontrolled use of antibiotics and natural evolution, many
pathogenic microorganisms have acquired resistance to currently available drugs …

Glycosylated antibiotics: New promising bacterial efflux pumps inhibitors

ZA Kamaz, HI Umar, P Doshi, P Suri - bioRxiv, 2021 - biorxiv.org
Background Antimicrobial resistance is considered a major concern problem; bacteria have
evolved mechanisms to overcome antibiotics' action through evolutionary process. One …

Identification of potential biogenic chalcones against antibiotic resistant efflux pump (AcrB) via computational study

S Rathod, S Dey, S Pawar, R Dhavale… - Journal of …, 2024 - Taylor & Francis
The cases of bacterial multidrug resistance are increasing every year and becoming a
serious concern for human health. Multidrug efflux pumps are key players in the formation of …

Nano-strategies in pursuit of efflux pump activeness in Acinetobacter baumannii and Pseudomonas aeruginosa

M Madhi, A Hasani, JS Mojarrad, MA Rezaee, G Zarrini… - Gene Reports, 2020 - Elsevier
Multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa are the two
bacteria notorious for nosocomial infections and threats in healthcare settings. Efflux pump …

[PDF][PDF] Anticancer drugs as potential inhibitors of AcrAB-TolC of multidrug resistant Escherichia coli: an in silico molecular modeling and docking study

P GUPTA, N RAI, P GAUTAM - Anticancer Drugs, 2015 - academia.edu
ABSTRACT Objective: Overexpression of AcrAB-TolC protein complex is often associated
with the virulence of multidrug-resistant bacteria. Development of an effective efflux pump …